Pomerantz LLP is investigating claims on behalf of investors ofGoHealth, Inc.(“GoHealth” or the “Company”)(NASDAQ: GOCO).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the […]

Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd.(“Biohaven” or the “Company”) (NYSE: BHVN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Biohaven and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

Pomerantz LLP announces that a class action lawsuit has been filed against Treace Medical Concepts, Inc(“Treace Medical” or the “Company”)(NASDAQ: TMCI). Such investors are advised to contact DaniellePeyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc.(“Zenas” or the “Company”)(NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Pomerantz LLP announces that a class action lawsuit has been filed against Ibotta, Inc. (“Ibotta” or the “Company”)(NYSE: IBTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Pomerantz LLP announces that a class action lawsuit has been filed against Napco Security Technologies, Inc.(“Napco” or the “Company”)(NASDAQ: NSSC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares

Pomerantz LLP announces that a class action lawsuit has been filed against Open Lending Corporation. (“Open Lending” or the “Company”)(NASDAQ: LPRO).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc.(“West” or the “Company”)(NYSE: WST). Such investors are advised to contact DaniellePeyton at newaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated(“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact DaniellePeyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg

Pomerantz LLP announces that a class action lawsuit has been filed against Digimarc Corporation(“Digimarc” or the “Company”)(NASDAQ: DMRC).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The class